Back to Farallon Capital Management, L.L.C. Farallon Capital Management, L.L.C.

RCEL

7 quarters

Position history for Farallon Capital Management, L.L.C.Farallon Capital Management, L.L.C.'s holdings in Avita Medical, Inc.

No. Farallon Capital Management exited its RCEL (Avita Medical) position in Q3 2022. Its Q2 2022 13F listed 580,000 shares worth $2.8M. Farallon Capital Management first reported RCEL in Q1 2021 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$15.9M

Total Shares Change

-800,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q3
Latest
Exited
0
-100.0%
$00.0%$5.27
0
2022-Q2
Decreased
580,000
-27.5%
$2.8M0.0%$4.75
0
2022-Q1
Unchanged
800,000
0.0%
$6.8M0.0%$8.48
0
2021-Q4
Unchanged
800,000
0.0%
$9.6M0.0%$11.98
0
2021-Q3
Unchanged
800,000
0.0%
$14.2M0.1%$17.72
0
2021-Q2
Unchanged
800,000
0.0%
$16.4M0.1%$20.52
0
2021-Q1
New
800,000
-
$15.9M0.1%$19.82
39

Other major holders of RCEL: BlackRock Finance, Inc., BlackRock, Inc., Vanguard Group Inc.

Optional analytics helps us improve. How it’s used